Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis (Q28344947)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis	scientific article

Statements

scholarly article

0 references

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis (English)

0 references

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

author name string

J Roberts

1

0 references

K Schock

2

0 references

S Marino

3

0 references

V T Andriole

4

0 references

language of work or name

0 references

publication date

December 2000

0 references

Antimicrobial Agents and Chemotherapy

0 references

44

0 references

12

0 references

3381-8

0 references

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

In vitro activity of a new oral triazole, BMS-207147 (ER-30346)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Aspergillus infections: problems in diagnosis and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Fungal infections in patients with acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Saperconazole therapy in a rabbit model of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of fluconazole in experimental invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

2 June 2018

The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

2 June 2018

New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

27 November 2018

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

27 November 2018

Aspergillosis complicating neoplastic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New antifungal agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy in experimental invasive aspergillosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.44.12.3381-3388.2000

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28344947&oldid=1576379458"